Click for best price
Prostate Cancer Drugs Market Size, Share 2022
Market Analysis and Insights: Global Prostate Cancer Drugs Market
The global Prostate Cancer Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Prostate Cancer Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Prostate Cancer Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Prostate Cancer Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Prostate Cancer Drugs market.
Global Prostate Cancer Drugs Scope and Market Size
Prostate Cancer Drugs market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Prostate Cancer Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Prostate Cancer Drugs market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Hormonal Therapy
Chemotherapy
Immunotherapy
Targeted Therapy
Segment by Application
Clinics
Hospitals
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
AbbVie
Astellas Pharma
Astra Zeneca
Johnson & Johnson
Sanofi
GlaxoSmithKline
Merck Group
Novartis
Amgen
Bayer HealthCare
Ferring Pharmaceutical
Janssen Pharmaceuticals
Endo Pharmaceuticals
BMS
Takeda Pharmaceuticals
Northwest Biotherapeutics
Teva Pharmaceutical
Boehringer Ingelheim
Foresee Pharmaceuticals
Tokai Pharmaceuticals
Spectrum Pharmaceuticals
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes Prostate Cancer Drugs product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of Prostate Cancer Drugs, with price, sales, revenue, and global market share of Prostate Cancer Drugs from 2019 to 2022.
Chapter 3, the Prostate Cancer Drugs competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Prostate Cancer Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Prostate Cancer Drugs market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Prostate Cancer Drugs.
Chapter 13, 14, and 15, to describe Prostate Cancer Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 Prostate Cancer Drugs Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
| Report Attributes |
Report Details |
| Report Title |
Global and United States Prostate Cancer Drugs Market Report & Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
126 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Study Coverage
1.1 Prostate Cancer Drugs Product Introduction
1.2 Global Prostate Cancer Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global Prostate Cancer Drugs Sales in US$ Million for the Year 2017-2028
1.2.2 Global Prostate Cancer Drugs Sales in Volume for the Year 2017-2028
1.3 United States Prostate Cancer Drugs Outlook 2017 VS 2022 VS 2028
1.3.1 United States Prostate Cancer Drugs Sales in US$ Million for the Year 2017-2028
1.3.2 United States Prostate Cancer Drugs Sales in Volume for the Year 2017-2028
1.4 Prostate Cancer Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Prostate Cancer Drugs in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Prostate Cancer Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Prostate Cancer Drugs Market Dynamics
1.5.1 Prostate Cancer Drugs Industry Trends
1.5.2 Prostate Cancer Drugs Market Drivers
1.5.3 Prostate Cancer Drugs Market Challenges
1.5.4 Prostate Cancer Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Prostate Cancer Drugs Market Segment by Type
2.1.1 Hormonal Therapy
2.1.2 Chemotherapy
2.1.3 Immunotherapy
2.1.4 Targeted Therapy
2.2 Global Prostate Cancer Drugs Market Size by Type
2.2.1 Global Prostate Cancer Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Prostate Cancer Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Prostate Cancer Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Prostate Cancer Drugs Market Size by Type
2.3.1 United States Prostate Cancer Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Prostate Cancer Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Prostate Cancer Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Prostate Cancer Drugs Market Segment by Application
3.1.1 Clinics
3.1.2 Hospitals
3.1.3 Others
3.2 Global Prostate Cancer Drugs Market Size by Application
3.2.1 Global Prostate Cancer Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Prostate Cancer Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Prostate Cancer Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Prostate Cancer Drugs Market Size by Application
3.3.1 United States Prostate Cancer Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Prostate Cancer Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Prostate Cancer Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Prostate Cancer Drugs Competitor Landscape by Company
4.1 Global Prostate Cancer Drugs Market Size by Company
4.1.1 Top Global Prostate Cancer Drugs Manufacturers Ranked by Revenue (2021)
4.1.2 Global Prostate Cancer Drugs Revenue by Manufacturer (2017-2022)
4.1.3 Global Prostate Cancer Drugs Sales by Manufacturer (2017-2022)
4.1.4 Global Prostate Cancer Drugs Price by Manufacturer (2017-2022)
4.2 Global Prostate Cancer Drugs Concentration Ratio (CR)
4.2.1 Prostate Cancer Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Prostate Cancer Drugs in 2021
4.2.3 Global Prostate Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Prostate Cancer Drugs Manufacturing Base Distribution, Product Type
4.3.1 Global Prostate Cancer Drugs Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Prostate Cancer Drugs Product Type
4.3.3 Date of International Manufacturers Enter into Prostate Cancer Drugs Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Prostate Cancer Drugs Market Size by Company
4.5.1 Top Prostate Cancer Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States Prostate Cancer Drugs Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Prostate Cancer Drugs Sales by Players (2020, 2021 & 2022)
5 Global Prostate Cancer Drugs Market Size by Region
5.1 Global Prostate Cancer Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Prostate Cancer Drugs Market Size in Volume by Region (2017-2028)
5.2.1 Global Prostate Cancer Drugs Sales in Volume by Region: 2017-2022
5.2.2 Global Prostate Cancer Drugs Sales in Volume Forecast by Region (2023-2028)
5.3 Global Prostate Cancer Drugs Market Size in Value by Region (2017-2028)
5.3.1 Global Prostate Cancer Drugs Sales in Value by Region: 2017-2022
5.3.2 Global Prostate Cancer Drugs Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Prostate Cancer Drugs Market Size YoY Growth 2017-2028
6.1.2 North America Prostate Cancer Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Prostate Cancer Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Prostate Cancer Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 China Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.3 Europe
6.3.1 Europe Prostate Cancer Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe Prostate Cancer Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Prostate Cancer Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America Prostate Cancer Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Prostate Cancer Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Prostate Cancer Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 AbbVie
7.1.1 AbbVie Corporation Information
7.1.2 AbbVie Description and Business Overview
7.1.3 AbbVie Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.1.4 AbbVie Prostate Cancer Drugs Products Offered
7.1.5 AbbVie Recent Development
7.2 Astellas Pharma
7.2.1 Astellas Pharma Corporation Information
7.2.2 Astellas Pharma Description and Business Overview
7.2.3 Astellas Pharma Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Astellas Pharma Prostate Cancer Drugs Products Offered
7.2.5 Astellas Pharma Recent Development
7.3 Astra Zeneca
7.3.1 Astra Zeneca Corporation Information
7.3.2 Astra Zeneca Description and Business Overview
7.3.3 Astra Zeneca Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Astra Zeneca Prostate Cancer Drugs Products Offered
7.3.5 Astra Zeneca Recent Development
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Corporation Information
7.4.2 Johnson & Johnson Description and Business Overview
7.4.3 Johnson & Johnson Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Johnson & Johnson Prostate Cancer Drugs Products Offered
7.4.5 Johnson & Johnson Recent Development
7.5 Sanofi
7.5.1 Sanofi Corporation Information
7.5.2 Sanofi Description and Business Overview
7.5.3 Sanofi Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Sanofi Prostate Cancer Drugs Products Offered
7.5.5 Sanofi Recent Development
7.6 GlaxoSmithKline
7.6.1 GlaxoSmithKline Corporation Information
7.6.2 GlaxoSmithKline Description and Business Overview
7.6.3 GlaxoSmithKline Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.6.4 GlaxoSmithKline Prostate Cancer Drugs Products Offered
7.6.5 GlaxoSmithKline Recent Development
7.7 Merck Group
7.7.1 Merck Group Corporation Information
7.7.2 Merck Group Description and Business Overview
7.7.3 Merck Group Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Merck Group Prostate Cancer Drugs Products Offered
7.7.5 Merck Group Recent Development
7.8 Novartis
7.8.1 Novartis Corporation Information
7.8.2 Novartis Description and Business Overview
7.8.3 Novartis Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Novartis Prostate Cancer Drugs Products Offered
7.8.5 Novartis Recent Development
7.9 Amgen
7.9.1 Amgen Corporation Information
7.9.2 Amgen Description and Business Overview
7.9.3 Amgen Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Amgen Prostate Cancer Drugs Products Offered
7.9.5 Amgen Recent Development
7.10 Bayer HealthCare
7.10.1 Bayer HealthCare Corporation Information
7.10.2 Bayer HealthCare Description and Business Overview
7.10.3 Bayer HealthCare Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Bayer HealthCare Prostate Cancer Drugs Products Offered
7.10.5 Bayer HealthCare Recent Development
7.11 Ferring Pharmaceutical
7.11.1 Ferring Pharmaceutical Corporation Information
7.11.2 Ferring Pharmaceutical Description and Business Overview
7.11.3 Ferring Pharmaceutical Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Ferring Pharmaceutical Prostate Cancer Drugs Products Offered
7.11.5 Ferring Pharmaceutical Recent Development
7.12 Janssen Pharmaceuticals
7.12.1 Janssen Pharmaceuticals Corporation Information
7.12.2 Janssen Pharmaceuticals Description and Business Overview
7.12.3 Janssen Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Janssen Pharmaceuticals Products Offered
7.12.5 Janssen Pharmaceuticals Recent Development
7.13 Endo Pharmaceuticals
7.13.1 Endo Pharmaceuticals Corporation Information
7.13.2 Endo Pharmaceuticals Description and Business Overview
7.13.3 Endo Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Endo Pharmaceuticals Products Offered
7.13.5 Endo Pharmaceuticals Recent Development
7.14 BMS
7.14.1 BMS Corporation Information
7.14.2 BMS Description and Business Overview
7.14.3 BMS Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.14.4 BMS Products Offered
7.14.5 BMS Recent Development
7.15 Takeda Pharmaceuticals
7.15.1 Takeda Pharmaceuticals Corporation Information
7.15.2 Takeda Pharmaceuticals Description and Business Overview
7.15.3 Takeda Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.15.4 Takeda Pharmaceuticals Products Offered
7.15.5 Takeda Pharmaceuticals Recent Development
7.16 Northwest Biotherapeutics
7.16.1 Northwest Biotherapeutics Corporation Information
7.16.2 Northwest Biotherapeutics Description and Business Overview
7.16.3 Northwest Biotherapeutics Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.16.4 Northwest Biotherapeutics Products Offered
7.16.5 Northwest Biotherapeutics Recent Development
7.17 Teva Pharmaceutical
7.17.1 Teva Pharmaceutical Corporation Information
7.17.2 Teva Pharmaceutical Description and Business Overview
7.17.3 Teva Pharmaceutical Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.17.4 Teva Pharmaceutical Products Offered
7.17.5 Teva Pharmaceutical Recent Development
7.18 Boehringer Ingelheim
7.18.1 Boehringer Ingelheim Corporation Information
7.18.2 Boehringer Ingelheim Description and Business Overview
7.18.3 Boehringer Ingelheim Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.18.4 Boehringer Ingelheim Products Offered
7.18.5 Boehringer Ingelheim Recent Development
7.19 Foresee Pharmaceuticals
7.19.1 Foresee Pharmaceuticals Corporation Information
7.19.2 Foresee Pharmaceuticals Description and Business Overview
7.19.3 Foresee Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.19.4 Foresee Pharmaceuticals Products Offered
7.19.5 Foresee Pharmaceuticals Recent Development
7.20 Tokai Pharmaceuticals
7.20.1 Tokai Pharmaceuticals Corporation Information
7.20.2 Tokai Pharmaceuticals Description and Business Overview
7.20.3 Tokai Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.20.4 Tokai Pharmaceuticals Products Offered
7.20.5 Tokai Pharmaceuticals Recent Development
7.21 Spectrum Pharmaceuticals
7.21.1 Spectrum Pharmaceuticals Corporation Information
7.21.2 Spectrum Pharmaceuticals Description and Business Overview
7.21.3 Spectrum Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.21.4 Spectrum Pharmaceuticals Products Offered
7.21.5 Spectrum Pharmaceuticals Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Prostate Cancer Drugs Industry Chain Analysis
8.2 Prostate Cancer Drugs Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Prostate Cancer Drugs Distributors
8.3 Prostate Cancer Drugs Production Mode & Process
8.4 Prostate Cancer Drugs Sales and Marketing
8.4.1 Prostate Cancer Drugs Sales Channels
8.4.2 Prostate Cancer Drugs Distributors
8.5 Prostate Cancer Drugs Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Prostate Cancer Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Prostate Cancer Drugs Market Trends
Table 3. Prostate Cancer Drugs Market Drivers
Table 4. Prostate Cancer Drugs Market Challenges
Table 5. Prostate Cancer Drugs Market Restraints
Table 6. Global Prostate Cancer Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Prostate Cancer Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Prostate Cancer Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Prostate Cancer Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Prostate Cancer Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Prostate Cancer Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Prostate Cancer Drugs Revenue Share by Manufacturer, 2017-2022
Table 13. Global Prostate Cancer Drugs Sales by Manufacturer, (K MT), 2017-2022
Table 14. Global Prostate Cancer Drugs Sales Share by Manufacturer, 2017-2022
Table 15. Global Prostate Cancer Drugs Price by Manufacturer (2017-2022) & (USD/MT)
Table 16. Global Prostate Cancer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Prostate Cancer Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Drugs as of 2021)
Table 18. Top Players of Prostate Cancer Drugs in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Prostate Cancer Drugs Product Type
Table 20. Date of International Manufacturers Enter into Prostate Cancer Drugs Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Prostate Cancer Drugs Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Prostate Cancer Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Prostate Cancer Drugs Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Prostate Cancer Drugs Sales by Players, (K MT), 2020, 2021 & 2022
Table 26. United States Prostate Cancer Drugs Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Prostate Cancer Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Prostate Cancer Drugs Sales in Volume by Region (2017-2022) & (K MT)
Table 29. Global Prostate Cancer Drugs Sales in Volume Forecast by Region (2023-2028) & (K MT)
Table 30. Global Prostate Cancer Drugs Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Prostate Cancer Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Prostate Cancer Drugs Sales in Volume by Country (2017-2028) & (K MT)
Table 33. North America Prostate Cancer Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Prostate Cancer Drugs Sales in Volume by Region (2017-2028) & (K MT)
Table 35. Asia Pacific Prostate Cancer Drugs Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Prostate Cancer Drugs Sales in Volume by Country (2017-2028) & (K MT)
Table 37. Europe Prostate Cancer Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Prostate Cancer Drugs Sales in Volume by Country (2017-2028) & (K MT)
Table 39. Latin Americaa Prostate Cancer Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Prostate Cancer Drugs Sales in Volume by Country (2017-2028) & (K MT)
Table 41. Middle East and Africa Prostate Cancer Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. AbbVie Corporation Information
Table 43. AbbVie Description and Business Overview
Table 44. AbbVie Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 45. AbbVie Prostate Cancer Drugs Product
Table 46. AbbVie Recent Development
Table 47. Astellas Pharma Corporation Information
Table 48. Astellas Pharma Description and Business Overview
Table 49. Astellas Pharma Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 50. Astellas Pharma Product
Table 51. Astellas Pharma Recent Development
Table 52. Astra Zeneca Corporation Information
Table 53. Astra Zeneca Description and Business Overview
Table 54. Astra Zeneca Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 55. Astra Zeneca Product
Table 56. Astra Zeneca Recent Development
Table 57. Johnson & Johnson Corporation Information
Table 58. Johnson & Johnson Description and Business Overview
Table 59. Johnson & Johnson Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 60. Johnson & Johnson Product
Table 61. Johnson & Johnson Recent Development
Table 62. Sanofi Corporation Information
Table 63. Sanofi Description and Business Overview
Table 64. Sanofi Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 65. Sanofi Product
Table 66. Sanofi Recent Development
Table 67. GlaxoSmithKline Corporation Information
Table 68. GlaxoSmithKline Description and Business Overview
Table 69. GlaxoSmithKline Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 70. GlaxoSmithKline Product
Table 71. GlaxoSmithKline Recent Development
Table 72. Merck Group Corporation Information
Table 73. Merck Group Description and Business Overview
Table 74. Merck Group Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 75. Merck Group Product
Table 76. Merck Group Recent Development
Table 77. Novartis Corporation Information
Table 78. Novartis Description and Business Overview
Table 79. Novartis Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 80. Novartis Product
Table 81. Novartis Recent Development
Table 82. Amgen Corporation Information
Table 83. Amgen Description and Business Overview
Table 84. Amgen Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 85. Amgen Product
Table 86. Amgen Recent Development
Table 87. Bayer HealthCare Corporation Information
Table 88. Bayer HealthCare Description and Business Overview
Table 89. Bayer HealthCare Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 90. Bayer HealthCare Product
Table 91. Bayer HealthCare Recent Development
Table 92. Ferring Pharmaceutical Corporation Information
Table 93. Ferring Pharmaceutical Description and Business Overview
Table 94. Ferring Pharmaceutical Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 95. Ferring Pharmaceutical Product
Table 96. Ferring Pharmaceutical Recent Development
Table 97. Janssen Pharmaceuticals Corporation Information
Table 98. Janssen Pharmaceuticals Description and Business Overview
Table 99. Janssen Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 100. Janssen Pharmaceuticals Product
Table 101. Janssen Pharmaceuticals Recent Development
Table 102. Endo Pharmaceuticals Corporation Information
Table 103. Endo Pharmaceuticals Description and Business Overview
Table 104. Endo Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 105. Endo Pharmaceuticals Product
Table 106. Endo Pharmaceuticals Recent Development
Table 107. BMS Corporation Information
Table 108. BMS Description and Business Overview
Table 109. BMS Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 110. BMS Product
Table 111. BMS Recent Development
Table 112. Takeda Pharmaceuticals Corporation Information
Table 113. Takeda Pharmaceuticals Description and Business Overview
Table 114. Takeda Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 115. Takeda Pharmaceuticals Product
Table 116. Takeda Pharmaceuticals Recent Development
Table 117. Northwest Biotherapeutics Corporation Information
Table 118. Northwest Biotherapeutics Description and Business Overview
Table 119. Northwest Biotherapeutics Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 120. Northwest Biotherapeutics Product
Table 121. Northwest Biotherapeutics Recent Development
Table 122. Teva Pharmaceutical Corporation Information
Table 123. Teva Pharmaceutical Description and Business Overview
Table 124. Teva Pharmaceutical Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 125. Teva Pharmaceutical Product
Table 126. Teva Pharmaceutical Recent Development
Table 127. Boehringer Ingelheim Corporation Information
Table 128. Boehringer Ingelheim Description and Business Overview
Table 129. Boehringer Ingelheim Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 130. Boehringer Ingelheim Product
Table 131. Boehringer Ingelheim Recent Development
Table 132. Foresee Pharmaceuticals Corporation Information
Table 133. Foresee Pharmaceuticals Description and Business Overview
Table 134. Foresee Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 135. Foresee Pharmaceuticals Product
Table 136. Foresee Pharmaceuticals Recent Development
Table 137. Tokai Pharmaceuticals Corporation Information
Table 138. Tokai Pharmaceuticals Description and Business Overview
Table 139. Tokai Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 140. Tokai Pharmaceuticals Product
Table 141. Tokai Pharmaceuticals Recent Development
Table 142. Spectrum Pharmaceuticals Corporation Information
Table 143. Spectrum Pharmaceuticals Description and Business Overview
Table 144. Spectrum Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 145. Spectrum Pharmaceuticals Product
Table 146. Spectrum Pharmaceuticals Recent Development
Table 147. Key Raw Materials Lists
Table 148. Raw Materials Key Suppliers Lists
Table 149. Prostate Cancer Drugs Customers List
Table 150. Prostate Cancer Drugs Distributors List
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Prostate Cancer Drugs Product Picture
Figure 2. Global Prostate Cancer Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Prostate Cancer Drugs Market Size 2017-2028 (US$ Million)
Figure 4. Global Prostate Cancer Drugs Sales 2017-2028 (K MT)
Figure 5. United States Prostate Cancer Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Prostate Cancer Drugs Market Size 2017-2028 (US$ Million)
Figure 7. United States Prostate Cancer Drugs Sales 2017-2028 (K MT)
Figure 8. United States Prostate Cancer Drugs Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Prostate Cancer Drugs Market Share in Global, in Volume (K MT) 2017-2028
Figure 10. Prostate Cancer Drugs Report Years Considered
Figure 11. Product Picture of Hormonal Therapy
Figure 12. Product Picture of Chemotherapy
Figure 13. Product Picture of Immunotherapy
Figure 14. Product Picture of Targeted Therapy
Figure 15. Global Prostate Cancer Drugs Market Share by Type in 2022 & 2028
Figure 16. Global Prostate Cancer Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 17. Global Prostate Cancer Drugs Sales Market Share in Value by Type (2017-2028)
Figure 18. Global Prostate Cancer Drugs Sales by Type (2017-2028) & (K MT)
Figure 19. Global Prostate Cancer Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 20. Global Prostate Cancer Drugs Price by Type (2017-2028) & (USD/MT)
Figure 21. United States Prostate Cancer Drugs Market Share by Type in 2022 & 2028
Figure 22. United States Prostate Cancer Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 23. United States Prostate Cancer Drugs Sales Market Share in Value by Type (2017-2028)
Figure 24. United States Prostate Cancer Drugs Sales by Type (2017-2028) & (K MT)
Figure 25. United States Prostate Cancer Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 26. United States Prostate Cancer Drugs Price by Type (2017-2028) & (USD/MT)
Figure 27. Product Picture of Clinics
Figure 28. Product Picture of Hospitals
Figure 29. Product Picture of Others
Figure 30. Global Prostate Cancer Drugs Market Share by Application in 2022 & 2028
Figure 31. Global Prostate Cancer Drugs Sales in Value by Application (2017-2028) & (US$ Million)
Figure 32. Global Prostate Cancer Drugs Sales Market Share in Value by Application (2017-2028)
Figure 33. Global Prostate Cancer Drugs Sales by Application (2017-2028) & (K MT)
Figure 34. Global Prostate Cancer Drugs Sales Market Share in Volume by Application (2017-2028)
Figure 35. Global Prostate Cancer Drugs Price by Application (2017-2028) & (USD/MT)
Figure 36. United States Prostate Cancer Drugs Market Share by Application in 2022 & 2028
Figure 37. United States Prostate Cancer Drugs Sales in Value by Application (2017-2028) & (US$ Million)
Figure 38. United States Prostate Cancer Drugs Sales Market Share in Value by Application (2017-2028)
Figure 39. United States Prostate Cancer Drugs Sales by Application (2017-2028) & (K MT)
Figure 40. United States Prostate Cancer Drugs Sales Market Share in Volume by Application (2017-2028)
Figure 41. United States Prostate Cancer Drugs Price by Application (2017-2028) & (USD/MT)
Figure 42. North America Prostate Cancer Drugs Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 43. North America Prostate Cancer Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 44. U.S. Prostate Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 45. Canada Prostate Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 46. Europe Prostate Cancer Drugs Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 47. Europe Prostate Cancer Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 48. Germany Prostate Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. France Prostate Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. U.K. Prostate Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Italy Prostate Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Russia Prostate Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. Asia-Pacific Prostate Cancer Drugs Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 54. Asia-Pacific Prostate Cancer Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 55. China Prostate Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. Japan Prostate Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. South Korea Prostate Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. India Prostate Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Australia Prostate Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. China Taiwan Prostate Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Indonesia Prostate Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Thailand Prostate Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Malaysia Prostate Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Latin America Prostate Cancer Drugs Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 65. Latin America Prostate Cancer Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 66. Mexico Prostate Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Brazil Prostate Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Argentina Prostate Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Middle East & Africa Prostate Cancer Drugs Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 70. Middle East & Africa Prostate Cancer Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 71. Turkey Prostate Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. Saudi Arabia Prostate Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. UAE Prostate Cancer Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. Prostate Cancer Drugs Value Chain
Figure 75. Prostate Cancer Drugs Production Process
Figure 76. Channels of Distribution
Figure 77. Distributors Profiles
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed
